Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease.

Alzheimer’s & Dementia: Translational Research & Clinical Interventions(2023)

引用 0|浏览2
暂无评分
摘要
The disease-progression models show a clear treatment effect of donanemab on clinical efficacy regardless of baseline disease severity.
更多
查看译文
关键词
alzheimer disease,efficacy relationship,modeling
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要